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3300 had abnormal apo B/apo A ratio of which 3089 (91%) had CAD.
Of 2920 patients with normal LDL levels (<100 mg), 2454 patients
had abnormal apo B/apo A ratio of which 2200 (91%) had CAD. In
1946 patients on lipid lowering agents 1819 had abnormal apo
B/apo A ratio with all of them (100%) having CAD.
Conclusion: Discussions on which is the ‘‘most inﬂuential’’ lipid
parameter have been particularly unrewarding. This study ascer-
tains the importance of apolipoproteins B and A and their ratio in
relation to CAD. It substantiates the signiﬁcance of the apo B/apo A
ratio over conventional lipid proﬁle values for predicting CAD and
its severity.
Association of apo B/apoA ratio andCAD in patientswith history of
dyslipidemia on lipid lowering agents was found signiﬁcant. This
study has shown that statins have been effective in lowering LDL,
but have not shown commensurate changes in apo B levels.
Measurement of apo B and apo A should be added to the routine
lipid proﬁle assessment in order to know the atherogenic potential
of lipid disorders in a particular case.
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Background objective: The prevalence of right bundle branch block
(RBBB) in the setting of acute myocardial infarction (MI) ranges
from 1.6% to 10.9% (about 3–29% in pre-thrombolytic era). Many
studies, especially in the pre-thrombolytic era, associated the
presence of RBBB in presence of MI with higher mortality. The
analysis of HERO-2 trial elegantly demonstrated that in the setting
of acute coronary syndrome, presence of RBBBwhatever the onset,
is associated with high risk of death. Very few studies estimated
the angiographic burden in patients presenting with acute coron-
ary syndrome (STEMI and non-STEMI) and QRBBB. This research
was intended to analyze various clinical characteristics and cor-
onary angiographic ﬁndings in patients with ACS and QRBBB in
ECG during index hospitalization and also treatment outcome
Methods: This cross sectional study was conducted in department
of cardiology in a tertiary care center in Tamilnadu from February
2013 to February 2015. A total of 30 patients who were admitted to
coronary care unit with features of ACS and ECG evidence of QRBBB
(at presentation or during hospitalization) were included. Baseline
characteristics were obtained and risk factors assessment were
done. The patients underwent serial electrocardiography, chest X
ray, 2D echocardiography. Coronary angiogram was done in all
eligible patients and a detailed study of all coronary arteries were
noted. Standard diagnostic criteria were applied to diagnose RBBB
in ECG and to assess LV function by ECHO. Appropriate guidelines
were followed for the management of ACS, thrombolytic therapy
given in needed patients. Percutaneous interventions were per-
formed in patients with angiographically suitable lesions. Patients
were followed up throughout the hospital stay.
Results: Majority of patients were male (90%), predominant age
group affected was between 50 and 60 (40%), lowest age was 32
years, highest age was 75 years. Out of total 30 patients, 26 patients
diagnosed to have STEMI (86%), remaining 4 patients (14%) had
features of NSTEMI. Only one patient (3%) had inferior wall MI in
STEMI group, remaining patients (83%) had anterior wall MI. His-
tory of diabetes, hypertension, smoking were noted in 50%, 37%,
and 37% respectively. STEMI patients were categorized with Killip
grade. Majority of patients were at KC II (76%), about 7% of patients
were in KC III and 4 patients (15%) of patients at KC IV. Out of four
patients with QRBBB and cardiogenic shock (KC IV) only one could
be revived. Mortality rate of 75% at KC IV were noted, whereas
mortality in patients with acute MI without QRBBB is 57.8%. Left
ventricular ejection fraction was lower inmajority of patients with
QRBBB average of about 44%. LVEF correlated with presentation of
Killip class. Thrombolytic therapy was given to 18 patients (69% of
total STEMI group). In hospital mortality rate in ACS and QRBBB
was 10% (3 patients of total 30) with average duration of stay being
less than 6 h. Out of 30 patients who presented with QRBBB, half of
them did not show RBBB pattern on discharge, most of them had
received thrombolytic therapy (80%). Patients presenting early
(window period (WP) < 6 h) had shown higher rate of ECG resolu-
tion compared to patients presenting late(WP > 6 h) (72%vs 21%).
Twenty ﬁve patientswere submitted for coronary angiography and
if necessary intervened. Left main coronary artery was free of
disease in all patients. Left coronary artery is found to have sig-
niﬁcant stenosis in 60% of patients. Signiﬁcant osteo-proximal
lesion noted in 20%, proximal LAD astriding S1 seen in 32% of
patients, proximal LAD cut-off in 8% of patients. Majority of
patients with LAD disease had signiﬁcant lesion at the proximal
segment (87%). Associated mid LAD and distal LAD lesion were
seen in 36% and 8% of study group respectively. Lesions of LCX and
RCA were seen in 32%, 16% respectively. Five patients (20%) had
double vessel disease, two had TVD (8%). Statistical signiﬁcant
association was found between the presence of QRBBB and asso-
ciated osteo-proximal/proximal LAD lesion. On analyzing the
angiographic pattern in patients with ECG resolution of RBBB, only
4 of them showed recanalized LAD, rest had signiﬁcant lesions in
LAD.
Conclusion and interpretation: Presence of QRBBB in the setting of
acute coronary syndrome implicates patient is in high risk cate-
gory. Culprit artery in RBBB with ACS is LAD proximal lesion hence
the lower level of LVEF and higher Killip class. ECG resolution is
more observed in patients who received thrombolytic therapy and
who presented early to hospital but it did not necessarily indicate
that angiographical burden of the disease will be low.
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Background: To investigate the impact of intracoronary tiroﬁban
injection on the short term events during percutaneous coronary
intervention (PCI) in patients presenting with acute coronary syn-
drome (ACS).
Methods: This study is a randomized, double blind, prospective
one. The cases were enrolled in those ACS patients undergoing PCI
admitted during the period fromDecember 2013 toNovember 2014.
Patientswere included if they fulﬁll all of the following criteria: Age
≥18 years of age, ACSwith an indication for cardiac catheterization
being unstable angina (angina <12 h prior to hospitalization),
NSTEMI, STEMI treated >48 h previously by thrombolytic therapy,
CAD with visual estimated stenosis ≥70% in at least one epicardial
vessel suitable for stenting, planned coronary stenting as
primary intervention modality. Patients who had any of the fol-
lowing criteria were excluded from the study: SBP<80 mm of Hg,
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GPIIb-IIIa administrated within 2 weeks before study, CABGwithin
2 months or PCI within 6 months before study, STEMI undergone
thrombolytic undergone within 48 h, unprotected LMCA >50%
stenosis, sever coronary calciﬁcation, target lesion in SVG, acute
STEMI with a primary PCI strategy and contraindication to antic-
oagulant therapy.
The patients were randomized alternately to intracoronary and
intravenous tiroﬁban. Fifty seven patients were given intracoron-
ary tiroﬁban and taken as study population and ﬁfty eight patients
were given intravenous tiroﬁban and taken as control population.
In the control group, tiroﬁban was given intravenously as a bolus
(10 mg/kg over 3 min) followed by maintenance intravenous infu-
sion at 0.15 mg/kg/min for 36 h. In the study group, tiroﬁban was
administered as an intracoronary bolus injection (10 mg/kg over
3 min) followed by maintenance intravenous infusion at 0.15 mg/
kg/min for 36 h. All patients were evaluated at the end of 14 and 30
day period. Flow in the PCI-targeted coronary arterieswas assessed
by thrombolysis in myocardial infarction (TIMI) ﬂowgrade. Left
ventricular ejection fraction (LVEF) was assessed by standard 2-
dimensional echocardiography at 14 and 30 days after PCI. Major
adverse cardiac events (MACE), such as death, non-fatal myocar-
dial infarction or re-infarction, revascularization of targeted ves-
sels, or worsening left ventricular dysfunction, were also assessed
at 14 days and 30 days following PCI. Major and minor bleeding
complications within 14 days also evaluated.
Results: Comparedwith the control group, the study group showed
better TIMI ﬂow grades and TIMI myocardial perfusion grades
(TMPG) immediately after PCI ( p = 0.016 and 0.026, respectively).
The 14-day composite MACE rate was lower in the study group
(3.5% vs 17.5%, p = 0.030), but was similar between the 2 groups at
30 days following PCI (7.0% vs 1.7%, p = 0.350). The LVEF in the study
group was higher than in the control group 30 days following PCI
(67.4  6.2% vs 60.7  4.6%, p = 0.033). The 14-day bleeding compli-
cation ( p = 0.201) was similar between the 2 groups.
Conclusion: In patients with ACS undergoing primary PCI, intra-
coronary bolus administration of tiroﬁban is superior to intrave-
nous bolus injection for improving coronary ﬂow, myocardial
perfusion and short-term clinical outcome.
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Background: The aim of treatment for acute myocardial infarction
(AMI) is to restore full antegrade blood ﬂow in the infarct-related
artery and minimize ischemic damage to the myocardium. How-
ever, primary PCI is associated with a serious problem known as
the no-reﬂowphenomenon (thrombolysis inmyocardial infarction
(TIMI) ﬂow ≤2), which occurs in 5–25% of cases.
Methods: This is a case control study of all consecutive patients
with AMI admitted at our institution and underwent primary PCI
from August 2014 to February 2015 based on ACC/AHA guidelines.
Results: In the 181 patients who had undergone primary PCI, 47
(25.9%) showed an angiographic no-reﬂow phenomenon.
Multiple stepwise logistic regression analysis identiﬁed that reper-
fusion time >6 h (OR = 13.844, 95%CI 3.214–59.636, p = <0.001), age
>60 years (OR = 8.886, 95%CI 2.145–36.80, p = 0.003), a long target
lesion (OR = 8.637, 95%CI 1.975–37.768, p = 0.004), low initial TIMI
ﬂow (≤1) (OR = 20.861, 95%CI 1.739–250.290, p = 0.017) were the
independent predictors of the no-ﬂow phenomenon in our study.
Conclusions: In conclusion, the pathogenesis of no-reﬂow phe-
nomenon is complex and multifactorial. In the light of our recent
study, patients who are likely to develop the no-reﬂow phenom-
enon after primary PCI can be predicted by simple clinical and
angiographic features.
It is important to avoid or minimize trauma to the vessel, avoid
repetitive balloon dilatations and use the shortest stent if possible.
Because most patients with AMI have a combination of these
factors, combined treatment strategies should be preferred.
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Background: Acute myocardial infarction below 45 years of age
constitutes a speciﬁc subset of population having different risk
factors and clinical features and prognosis as compared to older
patients. The protection offered by young age has been slowly
taken away by the increased prevalence of risk factors for CHD in
adolescents such as smoking, obesity, and lack of physical activity.
Objective: The purpose of this study is to describe the risk factors,
clinical features, angiographic patterns and outcomes in AMI in
young patients (<45 years) and to compare the samewith the older
subjects (>45 years) and to study the various complications in 7
days follow up.
Material andmethods: The present studywas carried out at the LPS
institute of cardiology Kanpur. Total 150 cases of acute myocardial
infarction admitted in ICCU during 1st January 2014 to 1st January
2015 were enrolled and were categorized in two groups: (a) Group I
– age <45 years, b) Group II age ≥45 years. Fasting blood glucose,
fasting lipid proﬁle, serial ECGs and the cardiac enzymes (troponin
T and I) were evaluated. The risk factors which were studied were
hypertension, diabetes mellitus, smoking habits, overweight,
waist to hip ratio, hyperlipidemia and family history.
Results: Mean age of the cases was 38  7 and 68.2  5 in group I
and II respectively. The male and female ratio was 3:1 in group I
and 1.5:1 in group II. Atypical chest pain, sweating, dyspnea and
giddiness were less frequently in the younger group with AMI than
group II. Younger subjects arriving within 6 h of chest pain was
signiﬁcantly more as in no compared to older subjects (49/65 i.e.
75% vs 38/85 i.e. 45%, p = <0.05). Tobacco consumption was the
most common risk factor in group I (71% vs 25% in group II).
Anterior wall MI, (including lateral MI) was the most common
presentation present in 57.64% of the patients in group I vs 45%
in group II. The incidence of major complications like congestive
cardiac failure, arrhythmias, cardiogenic shock were signiﬁcantly
less in the younger group (50%, 20%, 5%) as compared to (75%, 55%,
15%) respectively in older group. Mortality was signiﬁcantly lower
in group (I) than (group II) 5% vs 20%. Angiography results showed
SVD in 48% patients in group I vs 25% in group II. TVD was present
in only 3% of the patients in group I vs 27% in group II. LMCA was
involved in 3% in group I vs 12% in group II. Normal or nonsigni-
ﬁcant coronaries were present in 18% in group I vs 2% in group II.
From these results we conclude that Myocardial infarction before
age 45 is a disease of men. Young patients tend to have less
extensive coronary artery lesions. Very low prevalence of Triple-
vessel disease is present. Young patients have more favourable in
hospital prognosis than their older counterparts. A sizeable pro-
portion of patients will have normal coronary arteries. Health
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